Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income	$ 125,529	$ 110,551
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,185	5,430
Non-cash stock-based expense	7,424	6,275
Loss (gain) on extinguishment of debt	181	(412)
Deferred income taxes	1,953	2,724
Distributions from investments	0	540
Equity in losses from investments	141	5,172
Net (gains) losses on investment securities	(373)	10,296
Equity in (earnings) losses from real estate ventures	(4,800)	4,240
Distributions from real estate ventures	4,091	2,986
Non-cash interest expense	1,814	3,333
Non-cash lease expense	2,597	2,530
Other	7	0
Changes in assets and liabilities:
Receivables	15,829	(11,519)
Inventories	3,184	8,514
Accounts payable and accrued liabilities	(11,198)	(21,099)
Amounts due under the Master Settlement Agreement	188,016	200,266
Litigation accruals	1,260	0
Other assets and liabilities, net	131	(810)
Net cash provided by operating activities	340,971	329,017
Cash flows from investing activities:
Sale of investment securities	9,492	21,152
Maturities of investment securities	58,563	49,789
Purchase of investment securities	(79,099)	(48,828)
Proceeds from sale or liquidation of long-term investments	4,062	4,413
Purchase of long-term investments	(9,361)	(4,312)
Investments in real estate ventures	(6,632)	(19,644)
Distributions from investments in real estate ventures	9,273	3,791
Increase in cash surrender value of life insurance policies	(1,263)	(1,268)
(Increase) decrease in restricted assets	(18)	5
Issuance of notes receivable	(500)	0
Proceeds from sale of fixed assets	3	0
Capital expenditures	(9,067)	(8,759)
Paydowns of investment securities	91	157
Net cash used in investing activities	(24,456)	(3,504)
Cash flows from financing activities:
Repurchase and repayments of debt	(8,420)	(12,246)
Borrowings under revolving credit facility	87,497	67,451
Repayments on revolving credit facility	(109,532)	(67,453)
Dividends on common stock	(94,716)	(96,636)
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting and exercise of stock options	(3,705)	0
Other	0	(938)
Net cash used in financing activities	(128,876)	(109,822)
Net increase in cash, cash equivalents and restricted cash	187,639	215,691
Cash, cash equivalents and restricted cash, beginning of period	250,374	194,849
Cash, cash equivalents and restricted cash, end of period	$ 438,013	$ 410,540